# ICATIBANT ACETATE
> **ANDA213222** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2021-05-21
## Drug
- **FDA Application Number:** ANDA213222
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ICATIBANT ACETATE
- **Generic name:** Icatibant Acetate
- **Active ingredients:** ICATIBANT ACETATE
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Discontinued
- **Sponsor:** GLENMARK PHARMS LTD
- **First approval:** 2021-05-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213222)
---
*AI Analytics · CC0 1.0*